Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib

Treatment with inhibitors of the receptor tyrosine kinase FLT3 are currently studied as promising therapies in acute myeloid leukemia (AML). However, only a subset of patients benefit from these treatments and the presen
Treatment with inhibitors of the receptor tyrosine kinase FLT3 are currently studied as promising therapies in acute myeloid leukemia (AML). However, only a subset of patients benefit from these treatments and the presence of activating mutations within FLT3 can predict response to a certain extent only. ...
show moreshow less

Metadaten
Author:Christoph Schaab, Felix S. Oppermann, Martin Klammer, Heike Pfeifer, Andreas Tebbe, Thomas Oellerich, Jürgen Krauter, Mark Levis, Alexander E. Perl, Henrik Daub, Björn Steffen, Klaus Godl, Hubert Serve
URN:urn:nbn:de:hebis:30:3-335815
DOI:http://dx.doi.org/10.1038/leu.2013.347
ISSN:1476-5551
ISSN:0887-6924
Pubmed Id:http://www.ncbi.nlm.nih.gov/pubmed?term=24247654
Parent Title (English):Leukemia
Publisher:Nature Publ. Group
Place of publication:Basingstoke
Document Type:Article
Language:English
Date of Publication (online):2014/05/06
Date of first Publication:2014/01/10
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2014/05/06
Volume:28
Issue:3
Pagenumber:4
First Page:716
Last Page:719
Note:
Copyright © 2014 Macmillan Publishers Limited This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
HeBIS PPN:364486996
Institutes:Medizin
Dewey Decimal Classification:610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 3.0

$Rev: 11761 $